| Style | Citing Format |
|---|---|
| MLA | De La Morena MT, et al.. "Long-Term Outcomes of 176 Patients With X-Linked Hyper-Igm Syndrome Treated With or Without Hematopoietic Cell Transplantation." Journal of Allergy and Clinical Immunology, vol. 139, no. 4, 2017, pp. 1282-1292. |
| APA | De La Morena MT, Leonard D, Torgerson TR, Cabralmarques O, Slatter M, Aghamohammadi A, Chandra S, Murguiafavela L, Bonilla FA, Kanariou M, Damrongwatanasuk R, Kuo CY, Dvorak CC, Meyts I, Chen K, Kobrynski L, Kapoor N, Richter D, Digiovanni D, ... Roifman CM (2017). Long-Term Outcomes of 176 Patients With X-Linked Hyper-Igm Syndrome Treated With or Without Hematopoietic Cell Transplantation. Journal of Allergy and Clinical Immunology, 139(4), 1282-1292. |
| Chicago | De La Morena MT, Leonard D, Torgerson TR, Cabralmarques O, Slatter M, Aghamohammadi A, Chandra S, et al.. "Long-Term Outcomes of 176 Patients With X-Linked Hyper-Igm Syndrome Treated With or Without Hematopoietic Cell Transplantation." Journal of Allergy and Clinical Immunology 139, no. 4 (2017): 1282-1292. |
| Harvard | De La Morena MT et al. (2017) 'Long-Term Outcomes of 176 Patients With X-Linked Hyper-Igm Syndrome Treated With or Without Hematopoietic Cell Transplantation', Journal of Allergy and Clinical Immunology, 139(4), pp. 1282-1292. |
| Vancouver | De La Morena MT, Leonard D, Torgerson TR, Cabralmarques O, Slatter M, Aghamohammadi A, et al.. Long-Term Outcomes of 176 Patients With X-Linked Hyper-Igm Syndrome Treated With or Without Hematopoietic Cell Transplantation. Journal of Allergy and Clinical Immunology. 2017;139(4):1282-1292. |
| BibTex | @article{ author = {De La Morena MT and Leonard D and Torgerson TR and Cabralmarques O and Slatter M and Aghamohammadi A and Chandra S and Murguiafavela L and Bonilla FA and Kanariou M and Damrongwatanasuk R and Kuo CY and Dvorak CC and Meyts I and Chen K and Kobrynski L and Kapoor N and Richter D and Digiovanni D and Dhalla F and Farmaki E and Speckmann C and Espanol T and Shcherbina A and Hanson IC and Litzman J and Routes JM and Wong M and Fuleihan R and Seneviratne SL and Small TN and Janda A and Bezrodnik L and Seger R and Raccio AG and Edgar JDM and Chou J and Abbott JK and Van Montfrans J and Gonzalezgranado LI and Bunin N and Kutukculer N and Gray P and Seminario G and Pasic S and Aquino V and Wysocki C and Abolhassani H and Dorsey M and Cunninghamrundles C and Knutsen AP and Sleasman J and Costa Carvalho BT and Condinoneto A and Grunebaum E and Chapel H and Ochs HD and Filipovich A and Cowan M and Gennery A and Cant A and Notarangelo LD and Roifman CM}, title = {Long-Term Outcomes of 176 Patients With X-Linked Hyper-Igm Syndrome Treated With or Without Hematopoietic Cell Transplantation}, journal = {Journal of Allergy and Clinical Immunology}, volume = {139}, number = {4}, pages = {1282-1292}, year = {2017} } |
| RIS | TY - JOUR AU - De La Morena MT AU - Leonard D AU - Torgerson TR AU - Cabralmarques O AU - Slatter M AU - Aghamohammadi A AU - Chandra S AU - Murguiafavela L AU - Bonilla FA AU - Kanariou M AU - Damrongwatanasuk R AU - Kuo CY AU - Dvorak CC AU - Meyts I AU - Chen K AU - Kobrynski L AU - Kapoor N AU - Richter D AU - Digiovanni D AU - Dhalla F AU - Farmaki E AU - Speckmann C AU - Espanol T AU - Shcherbina A AU - Hanson IC AU - Litzman J AU - Routes JM AU - Wong M AU - Fuleihan R AU - Seneviratne SL AU - Small TN AU - Janda A AU - Bezrodnik L AU - Seger R AU - Raccio AG AU - Edgar JDM AU - Chou J AU - Abbott JK AU - Van Montfrans J AU - Gonzalezgranado LI AU - Bunin N AU - Kutukculer N AU - Gray P AU - Seminario G AU - Pasic S AU - Aquino V AU - Wysocki C AU - Abolhassani H AU - Dorsey M AU - Cunninghamrundles C AU - Knutsen AP AU - Sleasman J AU - Costa Carvalho BT AU - Condinoneto A AU - Grunebaum E AU - Chapel H AU - Ochs HD AU - Filipovich A AU - Cowan M AU - Gennery A AU - Cant A AU - Notarangelo LD AU - Roifman CM TI - Long-Term Outcomes of 176 Patients With X-Linked Hyper-Igm Syndrome Treated With or Without Hematopoietic Cell Transplantation JO - Journal of Allergy and Clinical Immunology VL - 139 IS - 4 SP - 1282 EP - 1292 PY - 2017 ER - |